References
- Kannel WB, Castelli WP, Gordon T, et al: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 74:1–12, 1971
- Hatch FT, Lees RS: Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6:1–68, 1968
- Lees RS, Wilson DE, Schonfeld G, et al: The familial dyslipoproteinemias. Prog Med Genet 9:237–290, 1973
- Goldstein JL, Schrott HG, Hazzard WR, et al: Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52:1544–1568, 1973
- Lees RS: A progress report on lipoprotein phenotyping. (Editorial) J Lab Clin Med 82:529–533, 1973
- Carvalho AC, Colman RW, Lees RS: Platelet function in hyperlipoproteinemia. New Engl J Med 290:434–438, 1974
- Miettinen M, Turpeinen O, Karvonen MJ, et al: Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. Lancet 2:835–838, 1972
- Duncan GW, Gruber JO, Dewey CF Jr. et al: Evaluation of carotid stenosis by phonoangiography. New Engl J Med 293:1124–1128, 1975
- Wilson DE, Lees RS: Metabolic relationships among the plasma lipoproteins. J Clin Invest 51:1051–1057, 1972
- Olefsky J, Reaven GM, Farquhar JW: Effects of weight reduction on obesity: Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest 53:64–76, 1974
- Sturdevant RA, Pearce ML, Dayton S: Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New Engl J Med 288:24–27, 1973
- Dayton S, Pearce MI, Hashimoto S, et al: A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation 40 (Suppl II), 1969
- Barter PJ, Connor WE, Spector AA, et al: Lowering of serum cholesterol and triglyceride by para-aminosalicylic acid in hyperlipoproteinemia. Ann Intern Med 81:619–624, 1974
- Carvalho AC, Lees RS, Vaillancourt RA, et al: Intravascular coagulation in hyperlipidemia. Thromb Res 8:843–857, 1976
- Harker LA, Slichter SJ: Platelet and fibrinogen consumption in man. New Engl J Med 287:999–1005, 1972
- Fletcher AP, Alkjaersig N, O'Brien J, et al: Blood hypercoagulability and thrombosis. Trans Assoc Am Physicians 83:159–167, 1970
- Genton E, Gent M, Hirsch J, et al: Platelet-inhibiting drugs in thrombotic disease. New Engl J Med 293:1174–1178, 1236–1240, 1296–1300, 1975
- Coronary Drug Project: Clofibrate and niacin in coronary heart disease. JAMA 231:360–381, 1975